×
About 3,750 results

ALLMedicine™ Onychomycosis Center

Research & Reviews  1,551 results

Effect of Different Nail Penetration Enhancers in Solid Lipid Nanoparticles Containing ...
https://doi.org/10.1208/s12249-020-01893-9 10.1001/archderm.1997.03890460029004 10.1016/j.jaad.2014.01.893 10.1016/S1085-5629(97)80043-0 10.2165/00128071-200405040-00003 10.1186/1471-2334-7-102 10.1111/j.1439-0507.2007.01405.x 10.1016/J.NHTM.2017.01.002 10.3109/03639045.2011.637931 10.1111/j.1468-3083.2004.00988.x 10.3109/08982101003596125 10.3109/03639045.2013.788016 10.1016/j.ejps.2013.08.032 10.1016/j.ejps.2007.07.009 10.3390/pharmaceutics10040273 10.1208/s12249-016-0528-9 10.1208/s12249-013-9964-y 10.22159/ijpps.2019v11i12.35560 10.1208/s12249-013-9954-0 10.1016/j.ijpharm.2009.10.018 10.1016/j.colsurfb.2010.12.024 10.1016/j.ijpharm.2010.11.036 10.1590/s2175-97902017000115012 10.1186/s12879-015-1240-1 10.1111/j.1574-695X.2000.tb01529.x 10.1208/s12249-011-9742-7 10.3109/10717544.2014.914601 10.1208/s12249-011-9583-4 10.3109/21691401.2013.794351 10.3109/03639045.2014.931966 10.1016/j.ijpharm.2012.06.020 10.1016/j.jchromb.2009.09.032 10.1159/000324055 10.1016/j.jare.2016.03.003 10.1038/jid.1961.153 10.3109/10717544.2015.1099059 10.1166/jnd.2013.1031 10.2147/IJN.S68737 10.1016/j.ejpb.2012.06.015 10.22159/ajpcr.2018.v11s3.30040 10.4103/0975-1483.83765 10.1016/j.ejpb.2004.11.002 10.9734/BJPR/2013/2770
AAPS PharmSciTech; Abobakr FE, Fayez SM et. al.

Jan 6th, 2021 - Onychomycosis is considered a stubborn nail fungal infection that does not respond to conventional topical antifungal treatments. This study aimed to develop and characterize novel solid lipid nanoparticles (SLNs) formulae containing terbinafine H...

A Timeline of Onychomycosis Therapy and Future Directions.
https://www.ncbi.nlm.nih.gov/pubmed/33397567
Skinmed Geizhals S, Lipner SR

Jan 5th, 2021 - Onychomycosis was first described in the mid-1800's, and early treatment regimens involved applying corrosive substances and nail plate avulsion. It was not until the mid-1900's that more specific antifungal agents were utilized. Initially, only o...

The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itra...
https://doi.org/10.1097/MJT.0000000000001291
American Journal of Therapeutics; Jiang W, Yang Q et. al.

Jan 4th, 2021 - The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itraconazole Capsule in the Treatment of Onychomycosis.|2021|Jiang W,Yang Q,Cai H,Xu Q,Ju A,|

A cross-sectional study on dermatoses among underwater workers: a new clinical sign of ...
https://doi.org/10.1111/ijd.15387
International Journal of Dermatology References; Nikhila PK, Sukumarakurup S et. al.

Dec 30th, 2020 - The pattern of dermatoses among underwater workers is undocumented and, hence, worth studying. The objective of the study was to document the pattern of dermatoses among underwater workers in a tropical seaside area. A population-based cross-secti...

The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Myc...
https://doi.org/10.1007/s40257-020-00580-6 10.4103/ijdvl.IJDVL_224_17 10.4103/ijd.IJD_206_17 10.1111/j.1439-0507.2008.01606.x 10.1128/MMBR.00016-10 10.1007/s11046-008-9100-9 10.1111/myc.12878 10.1111/j.1540-9740.2005.03435.x 10.1128/AAC.47.1.82-86.2003 10.1128/AAC.01600-05 10.1111/myc.12772 10.1128/AAC.00115-17 10.1128/AAC.02522-17 10.1111/1346-8138.14809 10.1016/j.mmcr.2019.09.001 10.1016/j.mycmed.2019.100903 10.1128/AAC.01126-19 10.1007/s00105-019-4431-7 10.1111/bjd.19146 10.1111/myc.13091 10.1007/s10096-018-3317-4 10.1016/j.mmcr.2017.07.003 10.4103/0019-5154.190120 10.4103/ijdvl.IJDVL_526_17 10.1128/AAC.01038-18 10.2147/IDR.S246025 10.1111/dth.14014 10.1111/pde.13411 10.2340/00015555-2455 10.1093/mmy/myx044 10.1111/bjd.19420 10.1111/myc.12794 10.1111/jdv.16394 10.1080/09546634.2019.1612835 10.1093/jac/dkaa111 10.1111/j.1439-0507.2006.01295.x 10.1007/s11046-016-0045-0 10.1016/j.ijantimicag.2017.03.021 10.2147/IDR.S61998 10.1128/AAC.02056-12 10.12688/f1000research.18646.1 10.1177/1203475417716362 10.1016/j.pdpdt.2020.101774 10.4103/ijdvl.IJDVL_853_18 10.1111/ced.13780
American Journal of Clinical Dermatology; Gupta AK, Renaud HJ et. al.

Dec 23rd, 2020 - Superficial mycoses are becoming increasingly resistant to current antifungal medications. As alternative therapeutic options are limited, the increasing frequency of reports of antifungal resistance is alarming. This epidemic parallels the rise o...

see more →

Guidelines  2 results

Fungal Nail Infections | Fungal Diseases | CDC
https://www.cdc.gov/fungal/nail-infections.html

Jan 24th, 2017 - Fungal nail infections, also called onychomycosis, are common infections of the fingernails or toenails that can cause the nail to become discolored, thick, and more likely to crack and break.

British Association of Dermatologists' guidelines for the management of onychomycosis 2...
https://doi.org/10.1111/bjd.13358
The British Journal of Dermatology; Ameen M, Lear JT et. al.

Nov 20th, 2014 - British Association of Dermatologists' guidelines for the management of onychomycosis 2014.|2014|Ameen M,Lear JT,Madan V,Mohd Mustapa MF,Richardson M,|administration & dosage,diagnosis,drug therapy,surgery,complications,diagnosis,drug therapy,surg...

see more →

Drugs  199 results see all →

Clinicaltrials.gov  1,795 results

Terbinafine - terbinafine tablet-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80aab848-8739-4259-a092-ed99d0f6a56d

Jan 12th, 2021 - Terbinafine tablets, USP are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH...

Tavaborole - tavaborole solution-Paddock Laboratories, LLC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc68c727-a77a-432e-8308-e88aea241b58

Jan 10th, 2021 - Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes. Tavaborole topical solution is an oxaborole antifungal indicated for...

Effect of Different Nail Penetration Enhancers in Solid Lipid Nanoparticles Containing ...
https://doi.org/10.1208/s12249-020-01893-9 10.1001/archderm.1997.03890460029004 10.1016/j.jaad.2014.01.893 10.1016/S1085-5629(97)80043-0 10.2165/00128071-200405040-00003 10.1186/1471-2334-7-102 10.1111/j.1439-0507.2007.01405.x 10.1016/J.NHTM.2017.01.002 10.3109/03639045.2011.637931 10.1111/j.1468-3083.2004.00988.x 10.3109/08982101003596125 10.3109/03639045.2013.788016 10.1016/j.ejps.2013.08.032 10.1016/j.ejps.2007.07.009 10.3390/pharmaceutics10040273 10.1208/s12249-016-0528-9 10.1208/s12249-013-9964-y 10.22159/ijpps.2019v11i12.35560 10.1208/s12249-013-9954-0 10.1016/j.ijpharm.2009.10.018 10.1016/j.colsurfb.2010.12.024 10.1016/j.ijpharm.2010.11.036 10.1590/s2175-97902017000115012 10.1186/s12879-015-1240-1 10.1111/j.1574-695X.2000.tb01529.x 10.1208/s12249-011-9742-7 10.3109/10717544.2014.914601 10.1208/s12249-011-9583-4 10.3109/21691401.2013.794351 10.3109/03639045.2014.931966 10.1016/j.ijpharm.2012.06.020 10.1016/j.jchromb.2009.09.032 10.1159/000324055 10.1016/j.jare.2016.03.003 10.1038/jid.1961.153 10.3109/10717544.2015.1099059 10.1166/jnd.2013.1031 10.2147/IJN.S68737 10.1016/j.ejpb.2012.06.015 10.22159/ajpcr.2018.v11s3.30040 10.4103/0975-1483.83765 10.1016/j.ejpb.2004.11.002 10.9734/BJPR/2013/2770
AAPS PharmSciTech; Abobakr FE, Fayez SM et. al.

Jan 6th, 2021 - Onychomycosis is considered a stubborn nail fungal infection that does not respond to conventional topical antifungal treatments. This study aimed to develop and characterize novel solid lipid nanoparticles (SLNs) formulae containing terbinafine H...

A Timeline of Onychomycosis Therapy and Future Directions.
https://www.ncbi.nlm.nih.gov/pubmed/33397567
Skinmed Geizhals S, Lipner SR

Jan 5th, 2021 - Onychomycosis was first described in the mid-1800's, and early treatment regimens involved applying corrosive substances and nail plate avulsion. It was not until the mid-1900's that more specific antifungal agents were utilized. Initially, only o...

The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itra...
https://doi.org/10.1097/MJT.0000000000001291
American Journal of Therapeutics; Jiang W, Yang Q et. al.

Jan 4th, 2021 - The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itraconazole Capsule in the Treatment of Onychomycosis.|2021|Jiang W,Yang Q,Cai H,Xu Q,Ju A,|

see more →

News  201 results

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.staging.medscape.com/viewarticle/935774

Aug 16th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.medscape.com/viewarticle/935774

Aug 16th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

FDA Drug Approvals, Dermatology — 2020 Midyear Review
https://reference.medscape.com/viewarticle/935244

Aug 13th, 2020 - Dupixent (dupilumab) - Indicated for moderate-to-severe atopic dermatitis not adequately controlled with topical prescription therapies or when those therapies are not advisable in children aged 6 years or older. Jublia (efinaconazole) - Indicatio...

Study Compares Pulse vs Continuous Therapy for Dermatophyte Toenail Onychomycosis
https://www.staging.medscape.com/viewarticle/932903

Jun 23rd, 2020 - There appear to be no differences in efficacy or safety between pulse and continuous regimens of terbinafine and no differences between pulse and continuous regimens of itraconazole for dermatophyte toenail onychomycosis, results from a systematic...

Nail growth
https://www.mdedge.com/familymedicine/article/218427/oncology/nail-growth?channel=203
MDedge Family Medicine;

Mar 5th, 2020 - The treatment failure with the terbinafine made onychomycosis unlikely, and the appearance of the finger did not suggest that this was a wart. So, the physician opted for a 4-mm punch biopsy of the lateral nail fold, which confirmed that this was.

see more →

Patient Education  2 results see all →